PVH
SRPT icon

Psagot Value Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Psagot Value Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17
Closed -$1K – 500
2021
Q1 		$1K Sell
17
-44,243
-100% -$4.08M ﹤0.01% 361
2020
Q4 		$7.55M Hold
44,260
– – 0.17% 107
2020
Q3 		$6.21M Sell
44,260
-55
-0.1% -$8.36K 0.16% 93
2020
Q2 		$7.11M Buy
+44,315
New +$6.03M 0.2% 81

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Psagot Value Holdings's SRPT Position: Q2 2021 in Review

Psagot Value Holdings sold out of Sarepta Therapeutics (SRPT) in Q2 2021, closing a stake of 17 shares — an estimated $1K sold.

Psagot Value Holdings first reported a position in SRPT in Q2 2020 and held it in 4 quarters. The position peaked at $7.55M in Q4 2020. 330 funds tracked by Wall St. Rank hold SRPT as of Q2 2021.

  • Psagot Value Holdings reported no remaining Sarepta Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Psagot Value Holdings sold 17 Sarepta Therapeutics shares in Q2 2021, an estimated $1K.
  • Psagot Value Holdings first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 4 quarters.
  • Psagot Value Holdings's Sarepta Therapeutics position peaked at $7.55M in Q4 2020.
  • 330 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2021.

Based on Psagot Value Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.